Deciphera Pharmaceuticals (DCPH)
(Delayed Data from NSDQ)
$25.51 USD
+0.01 (0.04%)
Updated May 24, 2024 04:00 PM ET
After-Market: $25.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Deciphera Pharmaceuticals, Inc. [DCPH]
Reports for Purchase
Showing records 1 - 20 ( 98 total )
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
All Is GIST Fine, While Waiting For "Vim" US and EU Filings For TGCT; Reit Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for DCPH 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Investors Feel Positive E"MOTION" Towards Vimseltinib and Qinlock
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Deciphera Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department